24/7 Market News Snapshot 02 May, 2025 – AirSculpt Technologies, Inc. Common Stock (NASDAQ:AIRS)

May 2, 2025

DENVER, Colo., 02 May, 2025 (www.247marketnews.com) – (NASDAQ:AIRS) are discussed in this article.
AirSculpt Technologies, Inc. (NASDAQ:AIRS), renowned for its premium body contouring procedures, has recently demonstrated significant market activity, with shares opening at $2.86 and experiencing notable fluctuations throughout the trading session, ultimately closing at $2.745—a steep decline of 21.46% from the previous day’s closing price of $2.26. This volatility has attracted considerable investor interest, as evidenced by a trading volume exceeding 1.03 million shares. Analysts are advised to monitor AirSculpt closely, as this movement could present various investment opportunities or indicate further market challenges.

In addition to its market performance, AirSculpt has released its financial results for the first quarter of 2025, reporting a total case volume of 3,076, marking a decline of 17.9% year-over-year. Revenues fell to $39.4 million, down 17.3% from the previous year’s figure of $47.6 million. Nevertheless, the company noted improved profitability compared to the preceding quarter, attributing this enhancement to effective cost management strategies.

CEO Yogi Jashnani expressed optimism, stating the Company is dedicated to executing its strategic initiatives amid a competitive market landscape. Early indicators from a revamped go-to-market strategy have shown promise in lead generation and operational performance, laying the groundwork for potential sequential revenue growth.

Looking forward, AirSculpt anticipates generating revenues in the range of $160 to $170 million for the full year, alongside projected Adjusted EBITDA of $16 to $18 million. The Company intends to fortify its lead generation efforts and expand consumer financing options while introducing a new standalone skin tightening service that has already attracted positive consumer interest.

With a successful track record of over 70,000 procedures, AirSculpt is committed to enhancing its market position and delivering exceptional patient experiences, all while focusing on long-term growth and shareholder value.

Related news for (AIRS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.